FY2024 EPS Estimates for Curaleaf Cut by Atb Cap Markets

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) – Stock analysts at Atb Cap Markets reduced their FY2024 EPS estimates for shares of Curaleaf in a research note issued to investors on Thursday, November 7th. Atb Cap Markets analyst F. Gomes now forecasts that the company will post earnings of ($0.24) per share for the year, down from their previous forecast of ($0.21). The consensus estimate for Curaleaf’s current full-year earnings is ($0.25) per share. Atb Cap Markets also issued estimates for Curaleaf’s Q4 2024 earnings at ($0.04) EPS and FY2025 earnings at ($0.14) EPS.

Several other brokerages have also recently weighed in on CURLF. Cormark cut shares of Curaleaf from a “moderate buy” rating to a “hold” rating in a research report on Thursday, November 7th. Needham & Company LLC reissued a “buy” rating and set a $6.25 price target on shares of Curaleaf in a research report on Thursday, August 8th.

Curaleaf Trading Down 22.1 %

Shares of CURLF opened at $1.66 on Monday. Curaleaf has a 52-week low of $1.64 and a 52-week high of $6.40. The company has a quick ratio of 0.50, a current ratio of 1.09 and a debt-to-equity ratio of 0.83. The firm’s fifty day moving average is $2.95 and its two-hundred day moving average is $3.77. The stock has a market cap of $1.08 billion, a PE ratio of -5.72 and a beta of 0.86.

About Curaleaf

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.